Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome
© Ponti et al.; licensee BioMed Central Ltd. 2012
Received: 29 July 2012
Accepted: 25 October 2012
Published: 29 October 2012
Café au lait spots (CALS) are common dermatologic findings that can at the same time arise in a variety of pathologic conditions such as Neurofibromatosis type 1 (NF1), together with numerous hereditary syndromes for which they represent either diagnostic criteria or associated elements (McCune Albright, Silver-Russell, LEOPARD, Ataxia-Telangiectasia). A review of the literature also revealed two cases of association with NBCCS. We report here the case of a female proband with CALS associated to Nevoid Basal Cell Carcinoma Syndrome (NBCCS) with known PTCH1 germline mutation (C.1348-2A>G) who had been misdiagnosed with NF1 in her childhood because of 5 CALS and cutaneous nodules. The patient presented a giant cell tumor of the skin, palmar and calcaneal epidermoidal cystic nodules, odontogenic keratocystic tumors and deformity of the jaw profile. Her family history brought both her brother and father to our attention because of the presence of KCOTs diagnosed at early age: after genetic testing, the same PTCH1 germline mutation was identified in the three family members. Clinical criteria are used for discerning NF1 diagnosis (size, number and onset age), while there are no definite guidelines concerning CALS except for their presence. In our experience, we have noted an association of CALS with NBCCS; this seems interesting because we already know clinical criteria are a dynamic entity and can be modified by epidemiologic evidences.
KeywordsCafé au lait spots Nevoid basal cell carcinoma syndrome PTCH1 mutation Neurofibromatosis type 1 Genodermatoses Hereditary cancer syndrome
Syndromes associated with café-au-lait macules
Gene or Locus
Cutaneous Clinical Features
Systemic Clinical Features
Multiple café-au-lait (>6), skin-fold freckling, cutaneous and plexiform neurofbromas
Macrocephaly, optic pathway glioma, skeletal dysplasia
Café-au-lait macules seen but not a criterion for diagnosis, neurofibromas
Acoustic neuromas, schwannomas, meningiomas, juvenile posterior subcapsular lenticular opacity
Multiple familial Café-au-lait
Without other stigmata of NF1
Legius (NF-1 like) syndrome
Multiple café-au-lait, skin-fold freckling
Without other stigmata of NF1
McCune Albright syndrome
Precocious puberty, other endocrinopathies, polyostotic fibrous dysplasia
Constitutional MMR deficiency syndrome
MLH1, MSH2, MSH6, PMS2
Adenomatous colonic polyps, multiple malignancies (medulloblastoma, lymphoma, glioblastoma)
Ring chromosome syndrome
Microcephaly, mental retardation, short stature
Leopard/multiple lentigenes syndrome
Café-au-lait, café-noir, lentigines
Cardiac conduction defects, ocular hypertelorism, pulmonary stenosis, growth retardation, hearing loss
Café-au-lait spots, Facial trichilemmomas, soft tissue tumors (lipomas, neuromas)
Cobblestoning of the oral mucosa, gastrointestinal polyps, breast carcinoma, thyroid adenoma and cancer
Banayan-Riley- Ruvalcaba syndrome
Pigmented genital macules, Facial trichilemmomas
Oral papillomas, gastrointestinal polyps, Macrocephaly, vascular anomalies
NAME (naevi, atrial mixoma, ephelides) syndrome
Cutaneous and ocular teleangectasias
Cerebellar ataxia, immunodeficiency, hypogonadism, lymphoreticular malignancy
Epidermal Nevus syndrome
Linear epidermal nevus
Mental retardation, seizures, movement disorders
X-chromosomal anomalies (XO karyotupe or Xp deletion)
Cutaneous lymphatic malformations
Short stature, broad chest, low hairline, low-set ears and webbed necks, swelling, gonadal dysfunction, congenital heart disease, hypothyroidism.
Multiple café au lait macules
Short stature, craniofacial and body asymmetry, microcephaly, congenital cardiac defects
FANCA, FANCB/C/D locus on chromosome 3, FANCE/F/G/H
Hyper- and hypopigmentation of the skin, mucocutaneous squamous cell carcinomas
Bone marrow failure, multiple congenital anomalies, mental retatrdation, microcephaly
Hypopigmented and hyperpigmented macules
Retarded growth and mental deficiency
Hypo- and hyper-pigmented spots; telangiectasias
Mental retardation, short stature
Yellowish-brown skin pigmentation
Astenia, diarrhoea, ataxia, splenomegalia, hemorrhagies, muscolar atrophia,
Macrocephaly, mental retardation, valvular dysfunction
Mental retardation, short stature, pulmonary valvular stenosis, Lisch nodules
Nevoid basal cell carcinoma syndrome (NBCC; also known as Gorlin syndrome; OMIM #109400), inherited in an autosomal dominant pattern, is characterized by a very wide spectrum of peculiar clinical manifestations. The most common features include multiple basal cell carcinomas, KCOTs, palmar and/or plantar pits and skeletal abnormalities (i.e. fused, bifid or splayed ribs). According to Kimonis et al., two major or one major and two minor criteria should contemporary exist in order to confirm the diagnosis of NBCCS. Most individuals present developmental defects, such as intracranial calcification, calcifications of the falx cerebri, and a variety of other benign or malignant tumors, including ovarian fibroma, medulloblastoma, rhabdomyosarcomas and cardiac fibromas. The major criteria included multiple BCCs or one BCC before 30 years, keratocysts of the jaw, palmar/plantar pits and lamellar calcification of the falx cerebri on skull radiograph. Minor criteria included spina bifida occulta or other vertebral anomalies, brachymetacarpaly in at least one limb, hypertelorism or telecanthus, frontal bossing, rib anomalies (bifid, synostosed, hypoplastic), ovarian fibroma, medulloblastoma, flame shaped lucencies in the phalanges, and brachymetacarpaly in the 4 limbs. One diagnosis was also established by the presence of a first degree relative with NBCC and one major or two minor criteria..
Our proband meets the diagnostic criteria for Gorlin syndrome since she presents two major criteria: multiple histologically proven odontogenic keratocysts occurred before the age of 20 and family history of NBCCS (father and brother). Moreover, molecular characterization reported the same germline PTCH1 mutation, C.1348-2A>G[8, 9]; we had hypothesized this mutation was related to a NBCCS subset with keratocysts only, until we discovered the presence of one basal cell carcinoma in the proband’s father. The entire family, which has been identified by a clinical approach starting from the KCOTs (8), is still under strict dermatologic follow-up.
We present here the case of an association between NBCCS and café au lait spots; the family history was peculiarly interesting since the proband was initially misdiagnosed with NF1 due the presence of 5 café-au-lait spots, which represent a common dermatologic finding either sporadic or associated to genodermatoses and other hereditary syndromes such as NF1, McCune-Albright syndrome and LEOPARD syndrome.
CALS vary from innocent findings to stigmata that connect different hereditary and sporadic syndromes. Histopathologically, they are nests of pigmented melanocytes, cells of neuroectodermal origin that migrate during the embryonic development: for this reason they sometimes have a somatotopic distribution, sometimes they follow dermatomes. They might for this reason relate to different neoplasms of common embryonic origin, not only in genodermatoses as NF1 but also in many other syndromes. We do not know how frequent is the presence of café-au-lait spots in Gorlin syndrome, but it might be interesting to further analyze this skin feature that might be useful in the detection of NBCCS. The literature review reported the case of a 10 year-old child diagnosed with NBCCS presenting CALS and neck pits, and a family composed by women and her two sons with NBCCS and CALS. In general, CALS range from the spectrum of innocent finding to that of an alarm bell for suspecting a hereditary syndrome; the threshold between the two is a clinical criteria, comprehending their number, their size and their onset age, at least in NF1, since in the majority of other syndromes there are no specific guidelines concerning CALS except for their presence. In our experience, we have noted an association of CALS with NBCCS; this seems interesting because we already know clinical criteria are a dynamic entity and can be modified by epidemiologic evidences, as it’s now happening to ameloblastoma in NBCCS diagnosis. Further clinical study will be necessary for the complete characterization of the clinical association between CALS and NBCCS.
Peripheral blood samples were collected from the proband and her first-degree relatives. Molecular analysis of PTCH1 was performed as previously described.Written informed consent, agreeing to peripheral blood sampling and genetic analysis, was obtained from each patient. Molecular analysis of PTCH1 was performed. The PTCH1 cDNA sequence from GenBank (Accession number U59464.1) was used as a reference sequence, where the A of the ATG translation initiation start site represents nucleotide +1. An Institutional Review Board (IRB) approval was obtained and the study in which the patients were enrolled was conducted according to the Declaration of Helsinki Principles. All patients provided their written informed consent for the management of personal data and for publication of their photographs before participating into the study. A copy of the written consent is available for review on request.
Basal cell carcinoma
Keratocystic odontogenic tumor
Nevoid basal cell carcinoma syndrome
Neurofibromatosis type 1.
The authors thank all colleagues who provided assistance: Luca Fabbiani, Silvana Ciardo and Sandro Radighieri.
- Gorlin RJ, Anderson RC, Moller JH: The leopard (multiple lentigines) syndrome revisited. Laryngoscope 1971, 81: 1674–1681.View ArticlePubMedGoogle Scholar
- Burwell RG, James NJ, Johnston DI: Cafe-au-lait spots in schoolchildren. Arch Dis Child 1982, 57: 631–632. 10.1136/adc.57.8.631View ArticlePubMedPubMed CentralGoogle Scholar
- Nunley KS, et al.: Predictive value of cafe au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Arch Dermatol 2009, 145: 883–887. 10.1001/archdermatol.2009.169View ArticlePubMedGoogle Scholar
- Ponti G, et al.: Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. Hered Cancer Clin Pract 2011, 9: 6. 10.1186/1897-4287-9-6View ArticlePubMedPubMed CentralGoogle Scholar
- Ponti G, et al.: Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. Crit Rev Oncol Hematol 2012. in pressGoogle Scholar
- Kimonis VE, et al.: Radiological features in 82 patients with nevoid basal cell carcinoma (NBCC or Gorlin) syndrome. Genet Med 2004, 6: 495–502. 10.1097/01.GIM.0000145045.17711.1CView ArticlePubMedGoogle Scholar
- Gorlin RJ, Sedano HO: The multiple nevoid basal cell carcinoma syndrome revisited. Birth Defects Orig Artic Ser 1971, 7: 140–148.PubMedGoogle Scholar
- Pastorino L, et al.: Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. PLoS One in press
- Ponti G, et al.: Patched homolog 1 gene mutation (p.G1093R9) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. Oncology Letters 2012, 4: 241–244.PubMedPubMed CentralGoogle Scholar
- Weston JA: Neural crest cell migration and differentiation. UCLA Forum Med Sci 1971, 14: 1–22.PubMedGoogle Scholar
- Balasundram S, Kovilpillai FJ, Hopper C: Nevoid basal cell carcinoma syndrome presenting with neck pits and cafe au lait patches. J Clin Pediatr Dent 2010, 35: 95–100.View ArticlePubMedGoogle Scholar
- Clendenning WE, Block JB, Radde IG: Basal Cell Nevus Syndrome. Arch Dermatol 1964, 90: 38–53. 10.1001/archderm.1964.01600010044011View ArticlePubMedGoogle Scholar
- Ponti G, et al.: Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. Fam Cancer 2012. in pressGoogle Scholar
- Pastorino L, Cusano R, Nasti S, et al.: Molecular Characterization of Italian Nevoid Basal Cell Carcinoma Syndrome Patients. Hum Mutat 2005, 25: 322–323.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.